{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:09:36Z","timestamp":1777612176948,"version":"3.51.4"},"reference-count":10,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.3201\/eid2206.152091","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T17:43:32Z","timestamp":1461692612000},"page":"1139-1141","source":"Crossref","is-referenced-by-count":35,"title":["<i>Neisseria gonorrhoeae<\/i>Resistant to Ceftriaxone and Cefixime, Argentina"],"prefix":"10.3201","volume":"22","author":[{"given":"Ricardo","family":"Gianecini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Oviedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciela","family":"Stafforini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Galarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2206.152091-201605171015-R1","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"key-10.3201\/eid2206.152091-201605171015-R2","doi-asserted-by":"crossref","unstructured":"Starnino S; GASP-LAC Working Group. Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, et al. Retrospective analysis of antimicrobial susceptibility trends (2000\u20132009) inNeisseria gonorrhoeaeisolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone. Sex Transm Dis. 2012;39:813\u201321.","DOI":"10.1097\/OLQ.0b013e3182631c9f"},{"key":"key-10.3201\/eid2206.152091-201605171015-R3","unstructured":"World Health Organization. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. Geneva: The Organization; 2013 [cited 2016 Feb 27]. http:\/\/apps.who.int\/iris\/bitstream\/10665\/85343\/1\/9789241505840_eng.pdf"},{"key":"key-10.3201\/eid2206.152091-201605171015-R4","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard, 9th ed. M07A9. Wayne (PA): The Institute; 2012."},{"key":"key-10.3201\/eid2206.152091-201605171015-R5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1128\/AAC.00788-10","article-title":"Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.","volume":"55","author":"Allen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.152091-201605171015-R6","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/jac\/dkq377","article-title":"Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.","volume":"65","author":"Whiley","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2206.152091-201605171015-R7","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2206.152091-201605171015-R8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/jac\/dkq187","article-title":"Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2.","volume":"65","author":"Whiley","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2206.152091-201605171015-R9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12879-015-1029-2","article-title":"Current and future antimicrobial treatment of gonorrhea: the rapidly evolving Neisseria gonorrhoeae continues to challenge.","volume":"15","author":"Unemo","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2206.152091-201605171015-R10","unstructured":"Gianecini R, Oviedo C, Bardossy E, Galarza P. Evaluation of antimicrobial susceptibility and resistance inNeisseria gonorrhoeae, Argentina, 2009\u20132013. In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy\/International Congress of Chemotherapy, San Diego, Sep 17\u201321, 2015. Washington (DC): American Society for Microbiology; 2015. Abstract C-672."}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/6\/15-2091_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:27:05Z","timestamp":1732922825000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/6\/15-2091_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2206.152091","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}